This inventor holds 7 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Protensive Limited, Cell Guidance Systems Limited, Protensive Limited (a Company Incorporated in England). Active years: 2005-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Royston, GB (2005 - 2006)
- Hertfordshire, GB (2006)
- Orwell Royston, GB (2006)
- Cambridge, GB (2024)
Company Filing History:

Years Active: 2005-2025
Title: The Innovative Contributions of Michael Jones
Introduction
Michael Jones is a distinguished inventor based in Royston, GB, known for his significant contributions to the field of neuroprotection. With a total of seven patents to his name, he has made remarkable strides in developing innovative solutions for retinal ganglion cell neurons.
Latest Patents
One of his latest patents is titled "Polyhedrin-based slow release growth factor system for neuroprotection of retinal ganglion cell neurons." This invention describes polyhedrin-based slow release growth factor systems and methods for neuroprotection of both host and donor retinal ganglion cell neurons. The delivery method involves altering cells by culturing them in a growth factor gradient, which is established through a polyhedra delivery system (PODS) that releases the growth factor to create the desired gradient.
Career Highlights
Throughout his career, Michael has worked with notable companies such as Protensive Limited and Cell Guidance Systems Limited. His work in these organizations has allowed him to apply his innovative ideas and contribute to advancements in medical technology.
Collaborations
Michael has collaborated with several professionals in his field, including Roshan Jeet Jee Jachuck and Ian Henderson. These partnerships have further enhanced his research and development efforts.
Conclusion
Michael Jones exemplifies the spirit of innovation through his patents and contributions to neuroprotection technology. His work continues to impact the field positively, showcasing the importance of inventive solutions in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile